We are pleased to announce that the DOST-PCHRD is now accepting research and development (R&D) proposals for funding in 2027. The call for proposals is for specific R&D priority areas under the National Unified Health Research Agenda (NUHRA 2023-2028) and the DOST Harmonized National R&D Agenda (HNRDA), which hinges on emerging and re-emerging health concerns that can be addressed by health research and other innovative solutions.

This call encourages public and private higher education institutes, research and development institutes and other qualified S&T-based organizations to conduct applied R&D and forge collaboration by and among organizations and communities involved in health R&D.

Important dates:

Proposal Acceptance Period: Concept Proposals: March 1-15, 2025, 5 PM || Full Blown Proposals: April 5 – May 15, 2025, 5 PM

Evaluation Period: May 16 – July 22, 2025

Release of Final Decision: End of July 2025 – Early August 2025

Target Project Implementation: January 2027

***The slide image was sourced from the DOST-PCHRD R&D Proposals.

For further details please download the attached 2025 PCHRD CFP (For 2027 Funding) Details

We wish to inform you that the UP System Office of International Linkages (UP OIL) is now accepting applications for financial assistance under the COOPERATE program for the conduct of international research/creative work of graduate students and their thesis/dissertation advisers.

The deadline for the submission of applications for those scheduled for departure from July to September 2025 is on 28 February 2025.

Application is open for all the UP graduate students at the master’s thesis/doctoral dissertation stage, and UP Manila Faculty or research advisers of a graduate student.

All pertinent information on the program, such as the guidelines and requirements, are available at COOPERATE – UP Office of International Linkages.  

Should you have any questions, please email us at upm-oil@up.edu.ph.

Thank you.

Please see the attached file containing information on a funding opportunity entitled “Innovations for Gram-Negative Antibiotic Discovery,”  a unique collaboration among three partners, the Novo Nordisk Foundation, Wellcome, and the Bill & Melinda Gates Foundation.

Through this GC RFP, the partners are launching a new initiative, the Gram-Negative Antibiotic Discovery Innovator (Gr-ADI). Gr-ADI will bring together funders, research institutions, and industry partners to address the problem of antimicrobial resistance, now the third leading cause of death globally.

The deadline of submission is on 25 March 2025.

More info in this link: https://gcgh.grandchallenges.org/challenge/innovations-gram-negative-antibiotic-discovery